Chimerix Inc Chimerix (NASDAQ: CMRX) Announces Acquisition Of Oncoceutics Chimerix, Inc. (NASDAQ: CMRX) disclosed that it has bought a clinical-stage biotechnology firm Oncoceutics, Inc. As per the acquisition, Chimerix is obliged to pay $78 million to the shareholders of Oncoceutics.